1. Home /
  2. Healthcare

Healthcare

Amazon's PillPack Is Coming to Market Soon

Amazon's PillPack Is Coming to Market Soon

PillPack, which sorts and ships medications across the U.S., now has a home on Amazon's main ecommerce site.

Align Technology Expected to Earn 84 cents a Share

Align Technology Expected to Earn 84 cents a Share

Align Technology revenue expected to rise 21.6% to $531.2 million.

HMO vs. PPO: What's the Difference in 2019?

HMO vs. PPO: What's the Difference in 2019?

Major differences between HMOs and PPOs is cost, size of the plan network, your ability to see specialists, and coverage for out-of-network services.

Biogen Shares Fall After Drugmaker Meets Earnings Estimates

Biogen Shares Fall After Drugmaker Meets Earnings Estimates

The stock dips after the drugmaker beats quarterly revenue estimates and earnings meet forecasts.

Anthem Drums Up Better-Than-Expected First-Quarter Earnings

Anthem Drums Up Better-Than-Expected First-Quarter Earnings

Healthcare provider Anthem reports first-quarter earnings that beat analysts' forecasts amid strong growth within its clinical and specialty services.

Waters Corp. Drowns Following Earnings Miss

Waters Corp. Drowns Following Earnings Miss

First-quarter earnings miss analysts' estimates and the company's forecast for the second quarter also is below forecasts.

Centene Climbs on First-Quarter Earnings Beat

Centene Climbs on First-Quarter Earnings Beat

The government insurance giant reports strong top- and bottom-line results and raises its 2019 forecast.

Intuitive Surgical Sinks on Analyst Target Price Cut

Intuitive Surgical Sinks on Analyst Target Price Cut

Intuitive Surgical shares tumbled after stock price target is cut at Canaccord.

A Tough Week for Biotech, the Candidates' Whipping Boy Again

A Tough Week for Biotech, the Candidates' Whipping Boy Again

Talk among a mammoth field of presidential candidates about drug price controls and an expansion of Medicare isn't helping biotech and health care stocks.

Amgen: This Beaten Down Blue Chip Is Priced To Own

Amgen: This Beaten Down Blue Chip Is Priced To Own

As the healthcare sector sells off, it's time to look for attractive value. You don't have to go any further than Amgen.